Literature DB >> 3258043

[Clinical significance of beta-lactamase inhibitors].

D Adam1.   

Abstract

Mesh:

Substances:

Year:  1988        PMID: 3258043     DOI: 10.1007/bf01713017

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


× No keyword cloud information.
  21 in total

1.  INHIBITION OF PENICILLINASES FROM GRAM-POSITIVE AND GRAM-NEGATIVE BACTERIA BY SUBSTRATE ANALOGUES.

Authors:  J M HAMILTON-MILLER; J T SMITH
Journal:  Nature       Date:  1964-03-07       Impact factor: 49.962

2.  6-beta-bromopenicillanic acid, a potent beta-lactamase inhibitor.

Authors:  R F Pratt; M J Loosemore
Journal:  Proc Natl Acad Sci U S A       Date:  1978-09       Impact factor: 11.205

3.  Clavulanic acid: a beta-lactamase-inhiting beta-lactam from Streptomyces clavuligerus.

Authors:  C Reading; M Cole
Journal:  Antimicrob Agents Chemother       Date:  1977-05       Impact factor: 5.191

4.  The semi-synthetic thienamycin derivative MK0787 and its properties with respect to a range of beta-lactamases from clinically relevant bacterial species.

Authors:  M H RIchmond
Journal:  J Antimicrob Chemother       Date:  1981-03       Impact factor: 5.790

5.  The carbapenem family.

Authors:  M J Basker
Journal:  J Antimicrob Chemother       Date:  1982-07       Impact factor: 5.790

6.  Synergy of amoxycillin combined with clavulanate and YTR 830 in experimental infections in mice.

Authors:  S C Aronoff; M R Jacobs; P H Labrozzi; S Yamabe
Journal:  J Antimicrob Chemother       Date:  1986-08       Impact factor: 5.790

7.  Conversion of cloxacillin into a progressive inhibitor of beta-lactamases by sulfonation and its activity against various types of these enzymes.

Authors:  A Yamaguchi; A Adachi; T Hirata; H Adachi; T Sawai
Journal:  J Antibiot (Tokyo)       Date:  1985-01       Impact factor: 2.649

8.  Inactivation of the RTEM beta-lactamase from Escherichia coli. Interaction of penam sulfones with enzyme.

Authors:  J Fisher; R L Charnas; S M Bradley; J R Knowles
Journal:  Biochemistry       Date:  1981-05-12       Impact factor: 3.162

9.  Olivanic acids, a family of beta-lactam antibiotics with beta-lactamase inhibitory properties produced by Streptomyces species. I. Detection, properties and fermentation studies.

Authors:  D Butterworth; M Cole; G Hanscomb; G N Rolinson
Journal:  J Antibiot (Tokyo)       Date:  1979-04       Impact factor: 2.649

10.  Inactivation of Bacillus cereus beta-lactamase I by 6 beta-bromopencillanic acid: mechanism.

Authors:  S A Cohen; R F Pratt
Journal:  Biochemistry       Date:  1980-08-19       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.